Abstract Background Portal hypertension (PH) is the main cause of complications and death in liver cirrhosis. The effect of oral administration of octreotide (OCT). a drug that reduces PH by the constriction of mesenteric arteries. is limited by a remarkable intestinal first-pass elimination. https://megavitamines.shop/product-category/senolytic-activator/